Search results
Results from the WOW.Com Content Network
Ultrasound Contrast Agents: Approved in the US and Europe [8] [28] [9] [29] C 4 F 10-1.9: Bubble: Perfluorobutane: Sonazoid: Daiichi Sankyo: Ultrasound Contrast Agent: Approved in Japan, [10] available in Korea, Norway, Taiwan, and China [30] C 5 F 12: 29: Bubble and/or Droplet: Dodecafluoropentane Emulsion, DDFPe: NanO 2, NVX-108, NVX-208 ...
However, the targeted technique has not yet been approved by the FDA for clinical use in the United States. Contrast-enhanced ultrasound is regarded as safe in adults, comparable to the safety of MRI contrast agents, and better than radiocontrast agents used in contrast CT scans. The more limited safety data in children suggests that such use ...
Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography. [1] It was approved for this use in the United States by the Food and Drug Administration in 1993. [2]
The most common example of molecular imaging used clinically today is to inject a contrast agent (e.g., a microbubble, metal ion, or radioactive isotope) into a patient's bloodstream and to use an imaging modality (e.g., ultrasound, MRI, CT, PET) to track its movement in the body.
A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. [1] Contrast agents absorb or alter external electromagnetism or ultrasound , which is different from radiopharmaceuticals , which emit radiation themselves.
Download as PDF; Printable version; ... MRI contrast agents (21 P) R. Radiocontrast agents (41 P) U. Ultrasound contrast agents (2 P) Pages in category "Contrast agents"
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Gadobutrol was first approved for use in MRIs of the central nervous system in the United States in 2011. It is currently manufactured by Bayer Healthcare Pharmaceuticals Inc. and marketed under the brand name Gadavist. [12] [13] In 2015, Gadavist was approved by the FDA as the first contrast agent safe for use in children under the age of 2 ...